Plain-English translation of NCT07178860 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is looking at what happens to people's lungs and overall health after they finish tuberculosis treatment. Researchers know that even though people are declared 'cured' after completing their TB medications, many experience ongoing breathing problems and other health issues for months or years afterward. This research aims to understand these long-term effects better so doctors can provide better care and support.
About half of people treated for tuberculosis develop lasting lung problems, and some experience heart, nerve, and mental health issues long after finishing treatment. The medical community has called for better follow-up care and guidelines to help TB survivors, but there is limited research from the UK to guide these efforts.
You likely qualify if…
You likely don't qualify if…
Participants will complete breathing tests (spirometry) and likely answer questions about their health and wellbeing since finishing TB treatment. The study is designed to track how people recover over time, so there may be follow-up visits or assessments over several months. Researchers will gather information about any ongoing symptoms or health challenges to help develop better care guidelines for TB survivors.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United Kingdom
Liverpool University Hospitals NHS Foundation Trust
Enrollment target
~50 participants
Started
September 2025
Primary completion
September 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Rebecca Nightingale, PhD
Liverpool School of Tropical Medicine
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.